These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14403007)

  • 1. The action of inhibitors on enzymes from human placentae.
    HOOPER KC
    J Physiol; 1959 Oct; 148(2):283-90. PubMed ID: 14403007
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of enzymes destroying oxytocin and vasopressin in human placentae.
    HOOPER KC; JESSUP DC
    J Physiol; 1959 Jun; 146(3):539-49. PubMed ID: 13665676
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasopressin-oxytocin antagonism in the human].
    FREY J; KERP L; REICHARDT W
    Klin Wochenschr; 1959 Apr; 37(7):325-9. PubMed ID: 13642766
    [No Abstract]   [Full Text] [Related]  

  • 4. [Competitive inhibition of the antidiuretic action of lysine-vasotocin by oxytocin in Rana esculenta].
    JARD S; MOREL F
    C R Hebd Seances Acad Sci; 1961 Jan; 252():339-41. PubMed ID: 13789551
    [No Abstract]   [Full Text] [Related]  

  • 5. [The circulation effect of 1-Hydrazinophthalazin].
    BEIN HJ; TRIPOD J; MEIER R
    Experientia; 1952 Feb; 8(2):74-5. PubMed ID: 14945413
    [No Abstract]   [Full Text] [Related]  

  • 6. Small molecule ligands for oxytocin and vasopressin receptors.
    Freidinger RM; Pettibone DJ
    Med Res Rev; 1997 Jan; 17(1):1-16. PubMed ID: 8979247
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation of antidiuretic activity of vasopressin by hypothalamic tissue in the presence of pyridoxal.
    ITOH S; KIKUCHI T
    Jpn J Physiol; 1959 Dec; 9():401-5. PubMed ID: 14406017
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antagonism of vasopressin-pitressin with glucocorticoids in the isolated intestine].
    BERMEJO GIMENEZ N; SANCHEZ MURIAS B
    Arch Inst Farmacol Exp (Madr); 1961; 13():109-19. PubMed ID: 13867982
    [No Abstract]   [Full Text] [Related]  

  • 9. Discovery and development of non-peptide antagonists of peptide hormone receptors.
    Pettibone DJ; Freidinger RM
    Biochem Soc Trans; 1997 Aug; 25(3):1051-7. PubMed ID: 9388600
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery, development, and some uses of vasopressin and oxytocin antagonists.
    Manning M; Sawyer WH
    J Lab Clin Med; 1989 Dec; 114(6):617-32. PubMed ID: 2687422
    [No Abstract]   [Full Text] [Related]  

  • 11. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of antidiuretic hormone by blood serum of the pregnant woman.
    CROXATTO H; VERA C; BARNAFI L
    Proc Soc Exp Biol Med; 1953; 83(4):784-6. PubMed ID: 13120885
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of antidiuretic hormone and oxytocin during pregnancy.
    HAWKER RW
    Q J Exp Physiol Cogn Med Sci; 1956 Jul; 41(3):301-8. PubMed ID: 13485346
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonism of the myometrial response to oxytocin and vasopressin by synthetic analogues.
    Melin P; Akerlund M; Vilhardt H
    Dan Med Bull; 1979 May; 26(3):126-8. PubMed ID: 446110
    [No Abstract]   [Full Text] [Related]  

  • 15. Premenstrual distress and what to do about it.
    BICKERS W; WOODS M
    Am J Nurs; 1952 Sep; 52(9):1087-9. PubMed ID: 12985611
    [No Abstract]   [Full Text] [Related]  

  • 16. The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human.
    Ohlsson B; Björgell O; Ekberg O; Darwiche G
    BMC Gastroenterol; 2006 Mar; 6():11. PubMed ID: 16542457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of cyclic and linear peptide antagonists of vasopressin and oxytocin: current status and future directions.
    Manning M; Chan WY; Sawyer WH
    Regul Pept; 1993 Apr; 45(1-2):279-83. PubMed ID: 8511357
    [No Abstract]   [Full Text] [Related]  

  • 18. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
    Chan WY; Hruby VJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):597-602. PubMed ID: 2969979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.
    Bisset GW; Clark BJ; Krejcí I; Polácek I; Rudinger J
    Br J Pharmacol; 1970 Oct; 40(2):342-60. PubMed ID: 4321760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists.
    Chan WY; Cao L; Hill PS; Hruby VJ
    Endocrinology; 1990 Apr; 126(4):2095-101. PubMed ID: 2318158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.